{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T05:07:01Z","timestamp":1790917621367,"version":"4.1.0"},"reference-count":22,"publisher":"Oxford University Press (OUP)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transactions of the Royal Society of Tropical Medicine and Hygiene"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1016\/j.trstmh.2006.02.011","type":"journal-article","created":{"date-parts":[[2006,5,27]],"date-time":"2006-05-27T07:15:13Z","timestamp":1148714113000},"page":"S26-S33","source":"Crossref","is-referenced-by-count":86,"special_numbering":"S1","title":["Oral miltefosine for the treatment of Indian visceral leishmaniasis"],"prefix":"10.1093","volume":"100","author":[{"given":"Shyam","family":"Sundar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.K.","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.P.","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.K.","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1016\/j.trstmh.2006.02.011_bib1","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/clind\/24.4.684","article-title":"Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years","volume":"24","author":"Berman","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.trstmh.2006.02.011_bib2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1086\/380638","article-title":"Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India","volume":"38","author":"Bhattacharya","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.trstmh.2006.02.011_bib3","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1016\/0006-2952(87)90543-0","article-title":"The activity of alkyl phosphorylcholines and related derivatives against Leishmania donovani","volume":"36","author":"Croft","year":"1987","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.trstmh.2006.02.011_bib4","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/0190-9622(93)70275-X","article-title":"Topical administration of hexadecylphosphocholine in patients with cutaneous lymphomas: results of a phase I\/II study","volume":"29","author":"Dummer","year":"1993","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.trstmh.2006.02.011_bib5","first-page":"314","article-title":"Changing response to diamidine compounds in cases of kala-azar unresponsive to antimonial","volume":"39","author":"Jha","year":"1991","journal-title":"J. Assoc. Physicians India"},{"key":"10.1016\/j.trstmh.2006.02.011_bib6","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1056\/NEJM199912093412403","article-title":"Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis","volume":"341","author":"Jha","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trstmh.2006.02.011_bib7","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1128\/AAC.36.8.1630","article-title":"Hexadecylphosphocholine: oral treatment of visceral leishmaniasis in mice","volume":"36","author":"Kuhlencord","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.trstmh.2006.02.011_bib8","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/S0140-6736(94)90406-5","article-title":"Amphotericin versus sodium stibogluconate in first-line treatment of Indian kala-azar","volume":"344","author":"Mishra","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.trstmh.2006.02.011_bib9","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/S0140-6736(98)04367-0","article-title":"Trial of oral miltefosine for visceral leishmaniasis","volume":"352","author":"Sundar","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.trstmh.2006.02.011_bib10","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/00034989958096","article-title":"Oral treatment of visceral leishmaniasis with miltefosine","volume":"93","author":"Sundar","year":"1999","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.trstmh.2006.02.011_bib11","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1086\/318121","article-title":"Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic","volume":"31","author":"Sundar","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.trstmh.2006.02.011_bib12","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1086\/318122","article-title":"Short-course of oral miltefosine for treatment of visceral leishmaniasis","volume":"31","author":"Sundar","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.trstmh.2006.02.011_bib13","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1056\/NEJMoa021556","article-title":"Oral miltefosine for Indian visceral leishmaniasis","volume":"347","author":"Sundar","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trstmh.2006.02.011_bib14","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/01.inf.0000066877.72624.cb","article-title":"Oral miltefosine treatment in children with mild to moderate Indian visceral leishmaniasis","volume":"22","author":"Sundar","year":"2003","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.trstmh.2006.02.011_bib15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1179\/000349804225003154","article-title":"A comparative evaluation of amphotericin B and sodium antimony gluconate, as first-line drugs in the treatment of Indian visceral leishmaniasis","volume":"98","author":"Thakur","year":"2004","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.trstmh.2006.02.011_bib16","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1136\/bmj.288.6421.895","article-title":"Comparison of regimens of treatment with sodium stibogluconate in kala-azar","volume":"288","author":"Thakur","year":"1984","journal-title":"Br. Med. J."},{"key":"10.1016\/j.trstmh.2006.02.011_bib17","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1136\/bmj.296.6636.1557","article-title":"Rationalisation of regimens of treatment of kala-azar with sodium stibogluconate in India: a randomised study","volume":"296","author":"Thakur","year":"1988","journal-title":"Br. Med. J."},{"key":"10.1016\/j.trstmh.2006.02.011_bib18","doi-asserted-by":"crossref","first-page":"435","DOI":"10.4269\/ajtmh.1991.45.435","article-title":"Comparison of regimes of treatment of antimony-resistant kala-azar patients: a randomized study","volume":"45","author":"Thakur","year":"1991","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.trstmh.2006.02.011_bib19","first-page":"103","article-title":"Evaluation of efficacy of longer durations of therapy of fresh cases of kala-azar with sodium stibogluconate","volume":"93","author":"Thakur","year":"1991","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.trstmh.2006.02.011_bib20","first-page":"170","article-title":"Evaluation of amphotericin B as a first line drug in comparison to sodium stibogluconate in the treatment of fresh cases of kala-azar","volume":"97","author":"Thakur","year":"1993","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.trstmh.2006.02.011_bib21","first-page":"113","article-title":"Hexadecylphosphocholine may produce reversible functional defects of the retinal pigment epithelium","volume":"2","author":"Theischen","year":"1993","journal-title":"Ger. J. Ophthalmol."},{"key":"10.1016\/j.trstmh.2006.02.011_bib22","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/BF01211805","article-title":"A dose-finding study of miltefosine (hexadecylphosphocholine) in patients with metastatic solid tumours","volume":"118","author":"Verweij","year":"1992","journal-title":"J. Cancer Res. Clin. Oncol."}],"container-title":["Transactions of the Royal Society of Tropical Medicine and Hygiene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/trstmh\/article-pdf\/100\/Supplement_1\/S26\/5329348\/100-Supplement_1-S26.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T21:27:22Z","timestamp":1555622842000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/trstmh\/article-lookup\/doi\/10.1016\/j.trstmh.2006.02.011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":22,"alternative-id":["S0035920306001106"],"URL":"https:\/\/doi.org\/10.1016\/j.trstmh.2006.02.011","relation":{},"ISSN":["0035-9203"],"issn-type":[{"value":"0035-9203","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}